Advisors Capital Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.7M Buy
859,918
+19,699
+2% +$496K 0.23% 129
2026
Q1
$21.2M Buy
840,219
+523,144
+165% +$13.3M 0.25% 124
2025
Q4
$8.09M Buy
317,075
+8,671
+3% +$222K 0.1% 179
2025
Q3
$7.9M Buy
308,404
+10,521
+4% +$267K 0.1% 178
2025
Q2
$7.53M Buy
+297,883
New +$7.39M 0.1% 173

Other funds holding IBDX

Advisors Capital Management's IBDX Position: Q2 2026 in Review

Advisors Capital Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 2.3% in Q2 2026, buying an estimated $496K and bringing the position to 859,918 shares worth $21.7M. The position accounts for 0.23% of the portfolio, ranked #129.

Advisors Capital Management first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Advisors Capital Management held 859,918 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $21.7M as of Q2 2026.
  • Advisors Capital Management bought 19,699 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $496K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.23% of Advisors Capital Management's portfolio in Q2 2026, its #129 holding.
  • Advisors Capital Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.